John J. Byrnes is a Professor of Medicine in the department of Hematology/Oncology from The University of Miami Health System
John J. Byrnes is a Professor of Medicine in the department of Hematology/Oncology from The University of Miami Health System
Research Intrest
Mechanism and treatment of thrombotic microangiopathy syndromes, including thrombocytic thrombocytopenia purpura (TTP) and hemolytic-uremic syndrome (HUS)
List of Publications
Trachtenberg B, et al…Byrnes J, Zambrano J, Heldman A, Hare J. Rational and design of the Transendocardial Injection or Autologous Human Cells )bone marrow or mesenchymal) in Chronic Left Ventricular Dysfunctional and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: a randomized, double–blinded, placebo controlled study of safety and efficacy. American Heart Journal, 2011; 161 (3):487-93
Hare, J M, et al. Byrnes J, et al. Heldman AW. Comparison of Allogenic vs. Autologous Bone Marrow Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy . JAMA 2012 Nov 6:: 1-11
Warsch,S and Byrnes,J. Emerging causes of iron deficiency anemia refractory to iron supplementation. World Journal of Gastroenterology. Accepted for publication